Current Seminars

05/04/2017 - 10:30 - Biopartnering Seminar Series

The MBiotech Biopartnering Seminar Series will resume on Tuesday September 5, 2017 in IB120 at 6:30pm. We hope to see you then!  

04/04/2017 - 18:30 - Biopartnering Seminar Series - Defining and Demonstrating the Value of New Health Technologies

Defining and Demonstrating the Value of New Health Technologies - Ferg Mills, Director of Strategic Consulting, Innomar Consulting Abstract: The presentation will briefly describe the key features of the reimbursement of health technologies in Canada, covering the roles of clinical and economic evidence, and addressing the evidence...

28/03/2017 - 18:30 - Biopartnering Seminar Series

Interactive Discussion in the role of an MSL and MA within a Medical Affairs Department in Pharma - Martin Latour, Medical Advisor, BioTherapeutics & Cross-Therapeutics, Department of Medical Affairs, AbbVie Canada Abstract:  The objective of this presentation will be to provide an overall description of the MA/MSL...

21/03/2017 - 18:30 - Biopartnering Seminar Series - Discussing the Vital Role Biometrics Plays to Support Pharma Development

Discussing the Vital Role Biometrics Plays to Support Pharma Development - Gregory Long, Director Clinical Data Management, Hoffmann-La Roche Abstract: Discussing the vital role Biometrics plays to support pharma development. We will start with a higher level view of the Biometrics function as a whole, and then take a deeper dive into the...

14/03/2017 - 18:30 - Biopartnering Seminar - Point-of-Care Testing, A Road Map Starting from CD4 Testing

Point-of-Care Testing, A Road Map Starting from CD4 Testing - Lu Chen, Director of Research, Chipcare Corp Abstract: Point-of-Care testing, by its name means the tests that are conducted at the place of patient care. Globally, the market is growing rapidly. Its increase popularity is based on its great fit with the shifting of healthcare...

Pages